Presenting a multi-marker response-adapted framework for venetoclax duration in acute myeloid leukemia. Adnan N. Ann Hematol 2026;105:414.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Adnan N. Presenting a multi-marker response-adapted framework for venetoclax duration in acute myeloid leukemia. Ann Hematol 2026;105:414.
PMID: 42733035